NCT03381105View on ClinicalTrials.gov

From PSA to Stockholm3: Study Part 1

Active, not recruitingOBSERVATIONAL
Enrollment

13,431

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2030

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSA and Stockholm3

The new Stockholm3 test and traditional PSA test

Trial Locations (1)

Unknown

Stavanger University Hospital, Stavanger

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Helse Stavanger HF

OTHER_GOV

NCT03381105 - From PSA to Stockholm3: Study Part 1 | Biotech Hunter | Biotech Hunter